Tech Company Financing Transactions
Tioga Pharmaceuticals Funding Round
Forward Ventures and New Leaf Venture Partners invested in a $24 million Series A funding round for Tioga Pharmaceuticals. The round was announced on 1/9/2006.
Transaction Overview
Company Name
Announced On
1/9/2006
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series A
Investors
Forward Ventures (Lead Investor)
New Leaf Venture Partners (James Niedel)
Proceeds Purpose
The capital will be used to fund a 600 patient phase IIb clinical trial for irritable bowel syndrome and a 130 patient phase IIa trial for post operative ileus.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4747 Executive Dr. 700
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Tioga Pharmaceuticals is engaged in the development of novel therapies for the treatment of gastrointestinal diseases. Tioga is developing asimadoline, a proprietary small molecule, for treating irritable bowel syndrome (IBS) and post operative ileus.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stuart Collinson
Chief Medical Officer
Dawn McGuire
Chief Operating Officer
Sophie Visonneau
Browse more venture capital transactions:
Prev: 1/6/2006: Loadstar Sensors venture capital transaction
Next: 1/9/2006: Xytis venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs